genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2019
Insys Therapeutics
Drug Discovery
Insys Shares Plunge After Warning of Chapter 11 Bankruptcy Filing
Cancer
Insys Founder, Four Former Executives Convicted of RICO Conspiracy Tied to Opioid Prescribing
Drug Discovery
Insys Weighs Next Steps after FDA Rejects NDA for Acute Pain Treatment Buvaya
Cancer
Insys Recommits to “High Ethical Standards” After Five Doctors Indicted on Federal Bribery, Kickback Charges
News
Insights
Cancer
Insys Founder Kapoor Indicted on Racketeering, Conspiracy Charges
A-Lists
Top 10 Wall Street Winners of 2014
Cancer
NeoPharm Closes Merger with Insys Therapeutics
Scroll Up
Scroll Up
